{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T08:36:32Z","timestamp":1789806992661,"version":"4.0.1"},"reference-count":62,"publisher":"SAGE Publications","issue":"17","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Antioxidants &amp; Redox Signaling"],"published-print":{"date-parts":[[2014,6]]},"abstract":"<jats:p>\n                    <jats:bold>\n                      <jats:italic toggle=\"yes\">Aims:<\/jats:italic>\n                    <\/jats:bold>\n                    Ischemic retinal diseases such as retinopathy of prematurity are major causes of blindness due to damage to the retinal microvasculature. Despite this clinical situation, retinopathy of prematurity is mechanistically poorly understood. Therefore, effective preventative therapies are not available. However, hypoxic-induced increases in reactive oxygen species (ROS) have been suggested to be involved with NADPH oxidases (NOX), the only known dedicated enzymatic source of ROS. Our major aim was to determine the contribution of NOX isoforms (1, 2, and 4) to a rodent model of retinopathy of prematurity.\n                    <jats:bold>\n                      <jats:italic toggle=\"yes\">Results:<\/jats:italic>\n                    <\/jats:bold>\n                    Using a genetic approach, we determined that only mice with a deletion of NOX1, but not NOX2 or NOX4, were protected from retinal neovascularization and vaso-obliteration, adhesion of leukocytes, microglial accumulation, and the increased generation of proangiogenic and proinflammatory factors and ROS. We complemented these studies by showing that the specific NOX inhibitor, GKT137831, reduced vasculopathy and ROS levels in retina. The source of NOX isoforms was evaluated in retinal vascular cells and neuro-glial elements. Microglia, the immune cells of the retina, expressed NOX1, 2, and 4 and responded to hypoxia with increased ROS formation, which was reduced by GKT137831.\n                    <jats:bold>\n                      <jats:italic toggle=\"yes\">Innovation:<\/jats:italic>\n                    <\/jats:bold>\n                    Our studies are the first to identify the NOX1 isoform as having an important role in the pathogenesis of retinopathy of prematurity.\n                    <jats:bold>\n                      <jats:italic toggle=\"yes\">Conclusions:<\/jats:italic>\n                    <\/jats:bold>\n                    Our findings suggest that strategies targeting NOX1 have the potential to be effective treatments for a range of ischemic retinopathies.\n                    <jats:italic toggle=\"yes\">Antioxid. Redox Signal.<\/jats:italic>\n                    20, 2726\u20132740.\n                  <\/jats:p>","DOI":"10.1089\/ars.2013.5357","type":"journal-article","created":{"date-parts":[[2013,9,22]],"date-time":"2013-09-22T10:43:51Z","timestamp":1379846631000},"page":"2726-2740","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":108,"title":["NADPH Oxidase, NOX1, Mediates Vascular Injury in Ischemic Retinopathy"],"prefix":"10.1177","volume":"20","author":[{"given":"Jennifer L.","family":"Wilkinson-Berka","sequence":"first","affiliation":[{"name":"Monash University","place":["Australia"]},{"name":"Baker IDI Heart and Diabetes Institute","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devy","family":"Deliyanti","sequence":"additional","affiliation":[{"name":"Monash University","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indrajeetsinh","family":"Rana","sequence":"additional","affiliation":[{"name":"Monash University","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia G.","family":"Miller","sequence":"additional","affiliation":[{"name":"Monash University","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Agrotis","sequence":"additional","affiliation":[{"name":"Monash University","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roksana","family":"Armani","sequence":"additional","affiliation":[{"name":"Monash University","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Szyndralewiez","sequence":"additional","affiliation":[{"name":"Genkyotex, Geneva, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirstin","family":"Wingler","sequence":"additional","affiliation":[{"name":"Maastricht University","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhian M.","family":"Touyz","sequence":"additional","affiliation":[{"name":"University of Glasgow","place":["United Kingdom"]},{"name":"University of Ottawa","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Cooper","sequence":"additional","affiliation":[{"name":"Monash University","place":["Australia"]},{"name":"Baker IDI Heart and Diabetes Institute","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin A.","family":"Jandeleit-Dahm","sequence":"additional","affiliation":[{"name":"Baker IDI Heart and Diabetes Institute","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald H.H.W.","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Maastricht University","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2014,6,10]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63001-5"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.08-1755"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-012-1010-9"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25938"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.022630199"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.08-2158"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2012.03.019"},{"key":"e_1_3_3_9_2","first-page":"526","article-title":"Erythropoietin deficiency decreases vascular stability in mice","volume":"118","author":"Chen J","year":"2008","unstructured":"Chen J, , Connor KM, , Aderman CM, , and Smith LE. Erythropoietin deficiency decreases vascular stability in mice. J Clin Invest, 118: 526\u2013533, 2008.","journal-title":"J Clin Invest"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.08-2521"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0b013e3283423f35"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00290.2007"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1591"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2008.156208"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.188136"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-9526"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature04482"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014665"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2005.12.049"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2011-0418OC"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2011.02724.x"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.07.063"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10633-009-9181-x"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm877"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2012.05.007"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2012.04.030"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000479"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm100773e"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-009-1116-4"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.siny.2011.08.007"},{"key":"e_1_3_3_31_2","first-page":"300","article-title":"Vaso-obliteration in the canine model of oxygen-induced retinopathy","volume":"37","author":"McLeod DS","year":"1996","unstructured":"McLeod DS, , Brownstein R, , and Lutty GA. Vaso-obliteration in the canine model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci, 37: 300\u2013311, 1996.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2005.068304"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.19.10836"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.36.6.1099"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011103"},{"key":"e_1_3_3_36_2","first-page":"22","article-title":"The regional distribution of vitamins E and C in mature and premature human retinas","volume":"29","author":"Nielsen JC","year":"1988","unstructured":"Nielsen JC, , Naash MI, , and Anderson RE. The regional distribution of vitamins E and C in mature and premature human retinas. Invest Ophthalmol Vis Sci, 29: 22\u201326, 1988.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1022474120512"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-7381"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2010.10.014"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(96)00479-0"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1996.01100140419009"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1103430"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(97)70031-3"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI29683"},{"key":"e_1_3_3_45_2","first-page":"840","article-title":"Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity","volume":"13","author":"Saito Y","year":"2007","unstructured":"Saito Y, , Geisen P, , Uppal A, , and Hartnett ME. Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity. Mol Vis, 13: 840\u2013853, 2007.","journal-title":"Mol Vis"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI42142"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1655-6"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.112.267054"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200005000-00004"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2008.08.005"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.2858"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI44158"},{"key":"e_1_3_3_53_2","first-page":"290","article-title":"Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity","volume":"37","author":"Stone J","year":"1996","unstructured":"Stone J, , Chan-Ling T, , Pe'er J, , Itin A, , Gnessin H, , and Keshet E. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. Invest Ophthalmol Vis Sci, 37: 290\u2013299, 1996.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-10685"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000046227.65158.F8"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2007.01.011"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1042\/CS20120212"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-011-2239-9"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.108.176008"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01249.x"},{"key":"e_1_3_3_61_2","unstructured":"World Health Organization. Global initiative for the elimination of avoidable blindness: action Plan 2006\u20132011. Geneva: World Health Organization; 2007. Available from: www.who.int\/blindness\/Vision2020_report.pdf (accessed July42012) 2007."},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0302117"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1009700107"}],"container-title":["Antioxidants &amp; Redox Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/ars.2013.5357","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/ars.2013.5357","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/ars.2013.5357","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:52:50Z","timestamp":1777377170000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/ars.2013.5357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":62,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["10.1089\/ars.2013.5357"],"URL":"https:\/\/doi.org\/10.1089\/ars.2013.5357","relation":{},"ISSN":["1523-0864","1557-7716"],"issn-type":[{"value":"1523-0864","type":"print"},{"value":"1557-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}